Abstract Library

#4633 Mini invasive pancreatectomy for pancreatic neuroendocrine tumours: Current state of management in France

Introduction: Pancreatic neuroendocrine tumours (NETs) accounts for 2% of pancreatic tumours and their management is challenging. Surgery is the most radical treatment, but for small lesions, parenchyma sparing techniques are also used.

Conference:

Presenting Author: Muzzolini M

Authors: Muzzolini M, de Ponthaud C, Gaujoux S,

Keywords: laparoscopic NETs surgical outcomes,

#3704 Impact of surgical approach on short- and long-term outcomes in gastroenteropancreatic neuroendocrine carcinomas

Introduction: Complete resection is the cornerstone of curative-intent treatment for gastroenteropancreatic neuroendocrine carcinomas (GEP-NECs) without distant metastases. However, there is a paucity of data on the impact of recent advancements in minimally invasive surgery (MIS), such as the utilization of laparoscopic and robotic approaches, on GEP-NEC patients’ outcomes.

Conference:

Presenting Author: Chen Q

Authors: Chen Q, Rhodin K, Li K, Kanu E, Zani S,

Keywords: Gastroenteropancreatic neuroendocrine carcinoma, Minimally Invasive Surgery, Open resection, Laparoscopic resection, Robotic resection, Outcome,

#3561 Minimally invasive laparoscopic and robotic versus open hepatic resection for NEN liver metastasis: Case matched study with propensity score matching

Introduction: Minimally invasive surgery has been widely considered as feasible and safe option in liver resection. However, little is known about the impact in the surgical therapy of NEN liver metastasis.

Conference:

Presenting Author: Pascher A

Authors: Pascher A, Morguel H, Katou S, Struecker B,

Keywords: neuroendocrine liver metastasis, liver surgery,

#3297 Update on the role of the robotic assisted surgery in the treatment of pancreatic neuroendocrine tumors in the context of MEN1

Introduction: Pancreatic surgery is technically demanding and robotic assisted surgery providing improved dexterity enables the adoption of minimally invasive pancreatic surgery. Pancreatic neuroendocrine tumors (pNETs) are rare with an incidence of one per 100,000 population, accounting for 1%-4% of all pancreatic tumors. Minimally invasive surgery has an established role in the treatment of patients with pNETs. PNETs are the second most common manifestation in patients with MEN1. The most common type of pNETs in MEN1 is a non-functional tumor.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Yiannakopoulou E,

Keywords: robotic assisted surgery, pNETs, MEN1,

#1844 Selective Approach in Surgical Treatment of Pancreatic Neuroendocrine Tumors

Introduction: Surgical resection is the main method in treating of pancreatic neuroendocrine tumors (pNETs) . Contemporary perioperative diagnostic can help using selective approaches, to perform organ-preserving (OP) procedures including operations with miniinvasive techniques (MI) such as robot – assisted (RA) or laparoscopic (La).

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Kaldarov A

Authors: Kaldarov A, Kriger A, Berelavichus S, Gorin D, Smirnov A,

Keywords: pancreatic neuroendocrine tumors, surgical treatment, robot, assisted, miniinvasive, laparoscopic,